+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Collagen Vascular Diseases Market - Global Forecast 2026-2032- Product Image
Collagen Vascular Diseases Market - Global Forecast 2026-2032- Product Image
New

Collagen Vascular Diseases Market - Global Forecast 2026-2032

  • PDF Icon

    Report

  • 191 Pages
  • January 2026
  • Region: Global
  • 360iResearch™
  • ID: 5924836
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The Collagen Vascular Diseases Market is experiencing dynamic change as precision therapeutics, advanced diagnostics, and evolving care delivery reshape industry strategies. Senior decision-makers now face a critical need to anticipate both innovation and regulatory change to competently navigate this complex, rapidly developing sector.

Market Snapshot: Collagen Vascular Diseases Market

The Collagen Vascular Diseases Market grew from USD 35.08 billion in 2025 to USD 38.21 billion in 2026. The segment is expected to expand at a CAGR of 9.09%, reaching USD 64.51 billion by 2032. Growth is attributed to the adoption of targeted biologics, developments in diagnostic platforms, and a pronounced move toward value-based care models. These factors are shaping a competitive market marked by scientific progress and operational adaptation.

Scope & Segmentation

This comprehensive report delivers actionable intelligence across all aspects of the collagen vascular diseases market, enabling strategic alignment for industry stakeholders. The analysis emphasizes the following areas:

  • Disease Subtypes: Includes dermatomyositis, rheumatoid arthritis, Sjogren's syndrome, systemic lupus erythematosus, systemic sclerosis, and a range of vasculitis forms (large, medium, and small vessel).
  • Therapeutic Classes: Covers biologics such as anti-TNF agents, B cell therapies, fusion proteins, and interleukin inhibitors, along with immunosuppressants, small molecule drugs, and corticosteroids.
  • Care Settings: Addresses clinics, hospitals, and research institutes, recognizing their differing procurement approaches and care pathway requirements.
  • Administration Routes: Explores injectable, oral, and topical therapies, with examination of their influence on adherence and system needs.
  • Distribution Pathways: Analyzes hospital pharmacies, retail settings, and online channels, each with its own impact on access and supply chain transparency.
  • Regions: Focuses on Americas, EMEA (Europe, Middle East, Africa), and Asia-Pacific, highlighting regulatory, clinical, and commercial considerations unique to each region.

Market segmentation allows leaders to target innovative therapies, adopt digital technologies to optimize patient monitoring, and tailor access strategies to regional regulatory environments.

Key Takeaways for Senior Decision-Makers

  • Therapeutic innovation is moving swiftly from empiric to mechanism-driven approaches, utilizing precision diagnostics and advanced biologics to improve outcomes in autoimmune and inflammatory diseases.
  • Integrated, multidisciplinary care models are essential in addressing the complexity of collagen vascular disorders, prompting the need for close coordination among healthcare providers and solution vendors.
  • Payer and health system scrutiny is driving industry emphasis on robust real-world evidence and outcomes-focused commercial models for product differentiation and reimbursement.
  • Resilient supply chain operations have become a strategic priority, prompting manufacturers to optimize inventory, logistics contingencies, and risk management to ensure steady therapy delivery.
  • Recognizing regional variation in regulation and reimbursement is vital; locally adapted market-entry and access plans improve competitiveness and patient reach.
  • Strategic partnerships—including those with academic institutions, diagnostic providers, and digital health collaborators—are increasingly important for market advantage and post-approval performance.

Tariff Impact and Market Resilience

United States tariffs enacted in 2025 created substantial effects on procurement and pricing for collagen vascular disease therapeutics. Companies responded by diversifying suppliers, expanding inventory management policies, and implementing more sophisticated logistics planning. These adaptive strategies increased operational complexity and capital needs, but secured marketplace continuity amid customs and cost variability. Simultaneously, health systems heightened procurement oversight, pushing manufacturers to optimize pricing and access. The environment spurred industry movement toward nearshoring, establishment of regional supply hubs, and growth in public-private alliances to strengthen distribution stability and preserve uninterrupted patient access.

Methodology & Data Sources

This report applies a rigorous mixed-methods approach, blending direct interviews with market participants and systematic secondary research, including literature, guidelines, regulatory review, and corporate data. Analytical techniques encompass scenario planning, policy scrutiny, and segment mapping, with findings subject to expert review to ensure validity and reproducibility.

Why This Report Matters

  • Enables strategic benchmarking and supports executive decision-making with clear perspectives on therapeutic, diagnostic, and commercialization developments in the collagen vascular diseases market.
  • Provides in-depth context for responding to shifting payer expectations, evolving regulatory frameworks, and heightened industry competition.
  • Guides senior leaders in investment, innovation prioritization, and agile response planning for diverse and changing regional markets.

Conclusion

The collagen vascular diseases market is characterized by rapid scientific advancement and increasing operational demands. Sustained success will depend on evidence-driven investment, manufacturing resilience, and regionalized access strategies tailored to dynamic market conditions.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Definition
1.3. Market Segmentation & Coverage
1.4. Years Considered for the Study
1.5. Currency Considered for the Study
1.6. Language Considered for the Study
1.7. Key Stakeholders
2. Research Methodology
2.1. Introduction
2.2. Research Design
2.2.1. Primary Research
2.2.2. Secondary Research
2.3. Research Framework
2.3.1. Qualitative Analysis
2.3.2. Quantitative Analysis
2.4. Market Size Estimation
2.4.1. Top-Down Approach
2.4.2. Bottom-Up Approach
2.5. Data Triangulation
2.6. Research Outcomes
2.7. Research Assumptions
2.8. Research Limitations
3. Executive Summary
3.1. Introduction
3.2. CXO Perspective
3.3. Market Size & Growth Trends
3.4. Market Share Analysis, 2025
3.5. FPNV Positioning Matrix, 2025
3.6. New Revenue Opportunities
3.7. Next-Generation Business Models
3.8. Industry Roadmap
4. Market Overview
4.1. Introduction
4.2. Industry Ecosystem & Value Chain Analysis
4.2.1. Supply-Side Analysis
4.2.2. Demand-Side Analysis
4.2.3. Stakeholder Analysis
4.3. Porter’s Five Forces Analysis
4.4. PESTLE Analysis
4.5. Market Outlook
4.5.1. Near-Term Market Outlook (0-2 Years)
4.5.2. Medium-Term Market Outlook (3-5 Years)
4.5.3. Long-Term Market Outlook (5-10 Years)
4.6. Go-to-Market Strategy
5. Market Insights
5.1. Consumer Insights & End-User Perspective
5.2. Consumer Experience Benchmarking
5.3. Opportunity Mapping
5.4. Distribution Channel Analysis
5.5. Pricing Trend Analysis
5.6. Regulatory Compliance & Standards Framework
5.7. ESG & Sustainability Analysis
5.8. Disruption & Risk Scenarios
5.9. Return on Investment & Cost-Benefit Analysis
6. Cumulative Impact of United States Tariffs 2025
7. Cumulative Impact of Artificial Intelligence 2025
8. Collagen Vascular Diseases Market, by Disease Indication
8.1. Dermatomyositis
8.2. Rheumatoid Arthritis
8.3. Sjogren's Syndrome
8.4. Systemic Lupus Erythematosus
8.5. Systemic Sclerosis
8.6. Vasculitis
8.6.1. Large Vessel Vasculitis
8.6.1.1. Giant Cell Arteritis
8.6.1.2. Takayasu's Arteritis
8.6.2. Medium Vessel Vasculitis
8.6.2.1. Kawasaki Disease
8.6.2.2. Polyarteritis Nodosa
8.6.3. Small Vessel Vasculitis
8.6.3.1. ANCA Associated Vasculitis
8.6.3.2. Cryoglobulinemic Vasculitis
8.6.3.3. IgA Vasculitis
9. Collagen Vascular Diseases Market, by Therapy Type
9.1. Biologics
9.1.1. Anti-TNF Agents
9.1.2. B Cell Depleting Therapies
9.1.3. Fusion Proteins
9.1.4. Interleukin Inhibitors
9.2. Immunosuppressants
9.3. Small Molecule Drugs
9.4. Steroids
10. Collagen Vascular Diseases Market, by Route Of Administration
10.1. Injectable
10.2. Oral
10.3. Topical
11. Collagen Vascular Diseases Market, by End User
11.1. Clinics
11.2. Hospitals
11.3. Research Institutes
12. Collagen Vascular Diseases Market, by Distribution Channel
12.1. Hospital Pharmacies
12.2. Online Pharmacies
12.3. Retail Pharmacies
13. Collagen Vascular Diseases Market, by Region
13.1. Americas
13.1.1. North America
13.1.2. Latin America
13.2. Europe, Middle East & Africa
13.2.1. Europe
13.2.2. Middle East
13.2.3. Africa
13.3. Asia-Pacific
14. Collagen Vascular Diseases Market, by Group
14.1. ASEAN
14.2. GCC
14.3. European Union
14.4. BRICS
14.5. G7
14.6. NATO
15. Collagen Vascular Diseases Market, by Country
15.1. United States
15.2. Canada
15.3. Mexico
15.4. Brazil
15.5. United Kingdom
15.6. Germany
15.7. France
15.8. Russia
15.9. Italy
15.10. Spain
15.11. China
15.12. India
15.13. Japan
15.14. Australia
15.15. South Korea
16. United States Collagen Vascular Diseases Market
17. China Collagen Vascular Diseases Market
18. Competitive Landscape
18.1. Market Concentration Analysis, 2025
18.1.1. Concentration Ratio (CR)
18.1.2. Herfindahl Hirschman Index (HHI)
18.2. Recent Developments & Impact Analysis, 2025
18.3. Product Portfolio Analysis, 2025
18.4. Benchmarking Analysis, 2025
18.5. Abbott Laboratories
18.6. AbbVie Inc.
18.7. Apollo Health and Lifestyle Limited
18.8. Augurex Life Sciences Corporation
18.9. Bayer AG
18.10. Beckman Coulter, Inc.
18.11. Bio-Rad Laboratories Inc.
18.12. Boehringer Ingelheim International GmbH
18.13. Bristol-Myers Squibb
18.14. Bristol-Myers Squibb Company
18.15. Eli Lilly and Company
18.16. Exagen Inc.
18.17. F. Hoffmann-La Roche Ltd
18.18. Getinge AB
18.19. Gilead Sciences, Inc.
18.20. GlaxoSmithKline plc
18.21. Illumina, Inc.
18.22. Johnson & Johnson
18.23. Laboratory Corporation of America Holdings
18.24. LeMaitre Vascular, Inc.
18.25. Merck KGaA
18.26. Novartis AG
18.27. PerkinElmer, Inc.
18.28. Pfizer Inc,
18.29. QIAGEN GmbH
18.30. Roche Holding AG
18.31. Sanofi S.A.
18.32. Siemens AG
18.33. Thermo Fisher Scientific, Inc.
18.34. UCB S.A.
List of Figures
FIGURE 1. GLOBAL COLLAGEN VASCULAR DISEASES MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 2. GLOBAL COLLAGEN VASCULAR DISEASES MARKET SHARE, BY KEY PLAYER, 2025
FIGURE 3. GLOBAL COLLAGEN VASCULAR DISEASES MARKET, FPNV POSITIONING MATRIX, 2025
FIGURE 4. GLOBAL COLLAGEN VASCULAR DISEASES MARKET SIZE, BY DISEASE INDICATION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 5. GLOBAL COLLAGEN VASCULAR DISEASES MARKET SIZE, BY THERAPY TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 6. GLOBAL COLLAGEN VASCULAR DISEASES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 7. GLOBAL COLLAGEN VASCULAR DISEASES MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 8. GLOBAL COLLAGEN VASCULAR DISEASES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 9. GLOBAL COLLAGEN VASCULAR DISEASES MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 10. GLOBAL COLLAGEN VASCULAR DISEASES MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 11. GLOBAL COLLAGEN VASCULAR DISEASES MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 12. UNITED STATES COLLAGEN VASCULAR DISEASES MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 13. CHINA COLLAGEN VASCULAR DISEASES MARKET SIZE, 2018-2032 (USD MILLION)
List of Tables
TABLE 1. GLOBAL COLLAGEN VASCULAR DISEASES MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 2. GLOBAL COLLAGEN VASCULAR DISEASES MARKET SIZE, BY DISEASE INDICATION, 2018-2032 (USD MILLION)
TABLE 3. GLOBAL COLLAGEN VASCULAR DISEASES MARKET SIZE, BY DERMATOMYOSITIS, BY REGION, 2018-2032 (USD MILLION)
TABLE 4. GLOBAL COLLAGEN VASCULAR DISEASES MARKET SIZE, BY DERMATOMYOSITIS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 5. GLOBAL COLLAGEN VASCULAR DISEASES MARKET SIZE, BY DERMATOMYOSITIS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 6. GLOBAL COLLAGEN VASCULAR DISEASES MARKET SIZE, BY RHEUMATOID ARTHRITIS, BY REGION, 2018-2032 (USD MILLION)
TABLE 7. GLOBAL COLLAGEN VASCULAR DISEASES MARKET SIZE, BY RHEUMATOID ARTHRITIS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 8. GLOBAL COLLAGEN VASCULAR DISEASES MARKET SIZE, BY RHEUMATOID ARTHRITIS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 9. GLOBAL COLLAGEN VASCULAR DISEASES MARKET SIZE, BY SJOGREN'S SYNDROME, BY REGION, 2018-2032 (USD MILLION)
TABLE 10. GLOBAL COLLAGEN VASCULAR DISEASES MARKET SIZE, BY SJOGREN'S SYNDROME, BY GROUP, 2018-2032 (USD MILLION)
TABLE 11. GLOBAL COLLAGEN VASCULAR DISEASES MARKET SIZE, BY SJOGREN'S SYNDROME, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 12. GLOBAL COLLAGEN VASCULAR DISEASES MARKET SIZE, BY SYSTEMIC LUPUS ERYTHEMATOSUS, BY REGION, 2018-2032 (USD MILLION)
TABLE 13. GLOBAL COLLAGEN VASCULAR DISEASES MARKET SIZE, BY SYSTEMIC LUPUS ERYTHEMATOSUS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 14. GLOBAL COLLAGEN VASCULAR DISEASES MARKET SIZE, BY SYSTEMIC LUPUS ERYTHEMATOSUS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 15. GLOBAL COLLAGEN VASCULAR DISEASES MARKET SIZE, BY SYSTEMIC SCLEROSIS, BY REGION, 2018-2032 (USD MILLION)
TABLE 16. GLOBAL COLLAGEN VASCULAR DISEASES MARKET SIZE, BY SYSTEMIC SCLEROSIS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 17. GLOBAL COLLAGEN VASCULAR DISEASES MARKET SIZE, BY SYSTEMIC SCLEROSIS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 18. GLOBAL COLLAGEN VASCULAR DISEASES MARKET SIZE, BY VASCULITIS, BY REGION, 2018-2032 (USD MILLION)
TABLE 19. GLOBAL COLLAGEN VASCULAR DISEASES MARKET SIZE, BY VASCULITIS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 20. GLOBAL COLLAGEN VASCULAR DISEASES MARKET SIZE, BY VASCULITIS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 21. GLOBAL COLLAGEN VASCULAR DISEASES MARKET SIZE, BY VASCULITIS, 2018-2032 (USD MILLION)
TABLE 22. GLOBAL COLLAGEN VASCULAR DISEASES MARKET SIZE, BY LARGE VESSEL VASCULITIS, BY REGION, 2018-2032 (USD MILLION)
TABLE 23. GLOBAL COLLAGEN VASCULAR DISEASES MARKET SIZE, BY LARGE VESSEL VASCULITIS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 24. GLOBAL COLLAGEN VASCULAR DISEASES MARKET SIZE, BY LARGE VESSEL VASCULITIS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 25. GLOBAL COLLAGEN VASCULAR DISEASES MARKET SIZE, BY LARGE VESSEL VASCULITIS, 2018-2032 (USD MILLION)
TABLE 26. GLOBAL COLLAGEN VASCULAR DISEASES MARKET SIZE, BY GIANT CELL ARTERITIS, BY REGION, 2018-2032 (USD MILLION)
TABLE 27. GLOBAL COLLAGEN VASCULAR DISEASES MARKET SIZE, BY GIANT CELL ARTERITIS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 28. GLOBAL COLLAGEN VASCULAR DISEASES MARKET SIZE, BY GIANT CELL ARTERITIS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 29. GLOBAL COLLAGEN VASCULAR DISEASES MARKET SIZE, BY TAKAYASU'S ARTERITIS, BY REGION, 2018-2032 (USD MILLION)
TABLE 30. GLOBAL COLLAGEN VASCULAR DISEASES MARKET SIZE, BY TAKAYASU'S ARTERITIS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 31. GLOBAL COLLAGEN VASCULAR DISEASES MARKET SIZE, BY TAKAYASU'S ARTERITIS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 32. GLOBAL COLLAGEN VASCULAR DISEASES MARKET SIZE, BY MEDIUM VESSEL VASCULITIS, BY REGION, 2018-2032 (USD MILLION)
TABLE 33. GLOBAL COLLAGEN VASCULAR DISEASES MARKET SIZE, BY MEDIUM VESSEL VASCULITIS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 34. GLOBAL COLLAGEN VASCULAR DISEASES MARKET SIZE, BY MEDIUM VESSEL VASCULITIS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 35. GLOBAL COLLAGEN VASCULAR DISEASES MARKET SIZE, BY MEDIUM VESSEL VASCULITIS, 2018-2032 (USD MILLION)
TABLE 36. GLOBAL COLLAGEN VASCULAR DISEASES MARKET SIZE, BY KAWASAKI DISEASE, BY REGION, 2018-2032 (USD MILLION)
TABLE 37. GLOBAL COLLAGEN VASCULAR DISEASES MARKET SIZE, BY KAWASAKI DISEASE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 38. GLOBAL COLLAGEN VASCULAR DISEASES MARKET SIZE, BY KAWASAKI DISEASE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 39. GLOBAL COLLAGEN VASCULAR DISEASES MARKET SIZE, BY POLYARTERITIS NODOSA, BY REGION, 2018-2032 (USD MILLION)
TABLE 40. GLOBAL COLLAGEN VASCULAR DISEASES MARKET SIZE, BY POLYARTERITIS NODOSA, BY GROUP, 2018-2032 (USD MILLION)
TABLE 41. GLOBAL COLLAGEN VASCULAR DISEASES MARKET SIZE, BY POLYARTERITIS NODOSA, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 42. GLOBAL COLLAGEN VASCULAR DISEASES MARKET SIZE, BY SMALL VESSEL VASCULITIS, BY REGION, 2018-2032 (USD MILLION)
TABLE 43. GLOBAL COLLAGEN VASCULAR DISEASES MARKET SIZE, BY SMALL VESSEL VASCULITIS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 44. GLOBAL COLLAGEN VASCULAR DISEASES MARKET SIZE, BY SMALL VESSEL VASCULITIS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 45. GLOBAL COLLAGEN VASCULAR DISEASES MARKET SIZE, BY SMALL VESSEL VASCULITIS, 2018-2032 (USD MILLION)
TABLE 46. GLOBAL COLLAGEN VASCULAR DISEASES MARKET SIZE, BY ANCA ASSOCIATED VASCULITIS, BY REGION, 2018-2032 (USD MILLION)
TABLE 47. GLOBAL COLLAGEN VASCULAR DISEASES MARKET SIZE, BY ANCA ASSOCIATED VASCULITIS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 48. GLOBAL COLLAGEN VASCULAR DISEASES MARKET SIZE, BY ANCA ASSOCIATED VASCULITIS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 49. GLOBAL COLLAGEN VASCULAR DISEASES MARKET SIZE, BY CRYOGLOBULINEMIC VASCULITIS, BY REGION, 2018-2032 (USD MILLION)
TABLE 50. GLOBAL COLLAGEN VASCULAR DISEASES MARKET SIZE, BY CRYOGLOBULINEMIC VASCULITIS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 51. GLOBAL COLLAGEN VASCULAR DISEASES MARKET SIZE, BY CRYOGLOBULINEMIC VASCULITIS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 52. GLOBAL COLLAGEN VASCULAR DISEASES MARKET SIZE, BY IGA VASCULITIS, BY REGION, 2018-2032 (USD MILLION)
TABLE 53. GLOBAL COLLAGEN VASCULAR DISEASES MARKET SIZE, BY IGA VASCULITIS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 54. GLOBAL COLLAGEN VASCULAR DISEASES MARKET SIZE, BY IGA VASCULITIS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 55. GLOBAL COLLAGEN VASCULAR DISEASES MARKET SIZE, BY THERAPY TYPE, 2018-2032 (USD MILLION)
TABLE 56. GLOBAL COLLAGEN VASCULAR DISEASES MARKET SIZE, BY BIOLOGICS, BY REGION, 2018-2032 (USD MILLION)
TABLE 57. GLOBAL COLLAGEN VASCULAR DISEASES MARKET SIZE, BY BIOLOGICS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 58. GLOBAL COLLAGEN VASCULAR DISEASES MARKET SIZE, BY BIOLOGICS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 59. GLOBAL COLLAGEN VASCULAR DISEASES MARKET SIZE, BY BIOLOGICS, 2018-2032 (USD MILLION)
TABLE 60. GLOBAL COLLAGEN VASCULAR DISEASES MARKET SIZE, BY ANTI-TNF AGENTS, BY REGION, 2018-2032 (USD MILLION)
TABLE 61. GLOBAL COLLAGEN VASCULAR DISEASES MARKET SIZE, BY ANTI-TNF AGENTS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 62. GLOBAL COLLAGEN VASCULAR DISEASES MARKET SIZE, BY ANTI-TNF AGENTS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 63. GLOBAL COLLAGEN VASCULAR DISEASES MARKET SIZE, BY B CELL DEPLETING THERAPIES, BY REGION, 2018-2032 (USD MILLION)
TABLE 64. GLOBAL COLLAGEN VASCULAR DISEASES MARKET SIZE, BY B CELL DEPLETING THERAPIES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 65. GLOBAL COLLAGEN VASCULAR DISEASES MARKET SIZE, BY B CELL DEPLETING THERAPIES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 66. GLOBAL COLLAGEN VASCULAR DISEASES MARKET SIZE, BY FUSION PROTEINS, BY REGION, 2018-2032 (USD MILLION)
TABLE 67. GLOBAL COLLAGEN VASCULAR DISEASES MARKET SIZE, BY FUSION PROTEINS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 68. GLOBAL COLLAGEN VASCULAR DISEASES MARKET SIZE, BY FUSION PROTEINS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 69. GLOBAL COLLAGEN VASCULAR DISEASES MARKET SIZE, BY INTERLEUKIN INHIBITORS, BY REGION, 2018-2032 (USD MILLION)
TABLE 70. GLOBAL COLLAGEN VASCULAR DISEASES MARKET SIZE, BY INTERLEUKIN INHIBITORS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 71. GLOBAL COLLAGEN VASCULAR DISEASES MARKET SIZE, BY INTERLEUKIN INHIBITORS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 72. GLOBAL COLLAGEN VASCULAR DISEASES MARKET SIZE, BY IMMUNOSUPPRESSANTS, BY REGION, 2018-2032 (USD MILLION)
TABLE 73. GLOBAL COLLAGEN VASCULAR DISEASES MARKET SIZE, BY IMMUNOSUPPRESSANTS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 74. GLOBAL COLLAGEN VASCULAR DISEASES MARKET SIZE, BY IMMUNOSUPPRESSANTS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 75. GLOBAL COLLAGEN VASCULAR DISEASES MARKET SIZE, BY SMALL MOLECULE DRUGS, BY REGION, 2018-2032 (USD MILLION)
TABLE 76. GLOBAL COLLAGEN VASCULAR DISEASES MARKET SIZE, BY SMALL MOLECULE DRUGS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 77. GLOBAL COLLAGEN VASCULAR DISEASES MARKET SIZE, BY SMALL MOLECULE DRUGS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 78. GLOBAL COLLAGEN VASCULAR DISEASES MARKET SIZE, BY STEROIDS, BY REGION, 2018-2032 (USD MILLION)
TABLE 79. GLOBAL COLLAGEN VASCULAR DISEASES MARKET SIZE, BY STEROIDS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 80. GLOBAL COLLAGEN VASCULAR DISEASES MARKET SIZE, BY STEROIDS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 81. GLOBAL COLLAGEN VASCULAR DISEASES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 82. GLOBAL COLLAGEN VASCULAR DISEASES MARKET SIZE, BY INJECTABLE, BY REGION, 2018-2032 (USD MILLION)
TABLE 83. GLOBAL COLLAGEN VASCULAR DISEASES MARKET SIZE, BY INJECTABLE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 84. GLOBAL COLLAGEN VASCULAR DISEASES MARKET SIZE, BY INJECTABLE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 85. GLOBAL COLLAGEN VASCULAR DISEASES MARKET SIZE, BY ORAL, BY REGION, 2018-2032 (USD MILLION)
TABLE 86. GLOBAL COLLAGEN VASCULAR DISEASES MARKET SIZE, BY ORAL, BY GROUP, 2018-2032 (USD MILLION)
TABLE 87. GLOBAL COLLAGEN VASCULAR DISEASES MARKET SIZE, BY ORAL, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 88. GLOBAL COLLAGEN VASCULAR DISEASES MARKET SIZE, BY TOPICAL, BY REGION, 2018-2032 (USD MILLION)
TABLE 89. GLOBAL COLLAGEN VASCULAR DISEASES MARKET SIZE, BY TOPICAL, BY GROUP, 2018-2032 (USD MILLION)
TABLE 90. GLOBAL COLLAGEN VASCULAR DISEASES MARKET SIZE, BY TOPICAL, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 91. GLOBAL COLLAGEN VASCULAR DISEASES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 92. GLOBAL COLLAGEN VASCULAR DISEASES MARKET SIZE, BY CLINICS, BY REGION, 2018-2032 (USD MILLION)
TABLE 93. GLOBAL COLLAGEN VASCULAR DISEASES MARKET SIZE, BY CLINICS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 94. GLOBAL COLLAGEN VASCULAR DISEASES MARKET SIZE, BY CLINICS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 95. GLOBAL COLLAGEN VASCULAR DISEASES MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2032 (USD MILLION)
TABLE 96. GLOBAL COLLAGEN VASCULAR DISEASES MARKET SIZE, BY HOSPITALS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 97. GLOBAL COLLAGEN VASCULAR DISEASES MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 98. GLOBAL COLLAGEN VASCULAR DISEASES MARKET SIZE, BY RESEARCH INSTITUTES, BY REGION, 2018-2032 (USD MILLION)
TABLE 99. GLOBAL COLLAGEN VASCULAR DISEASES MARKET SIZE, BY RESEARCH INSTITUTES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 100. GLOBAL COLLAGEN VASCULAR DISEASES MARKET SIZE, BY RESEARCH INSTITUTES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 101. GLOBAL COLLAGEN VASCULAR DISEASES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 102. GLOBAL COLLAGEN VASCULAR DISEASES MARKET SIZE, BY HOSPITAL PHARMACIES, BY REGION, 2018-2032 (USD MILLION)
TABLE 103. GLOBAL COLLAGEN VASCULAR DISEASES MARKET SIZE, BY HOSPITAL PHARMACIES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 104. GLOBAL COLLAGEN VASCULAR DISEASES MARKET SIZE, BY HOSPITAL PHARMACIES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 105. GLOBAL COLLAGEN VASCULAR DISEASES MARKET SIZE, BY ONLINE PHARMACIES, BY REGION, 2018-2032 (USD MILLION)
TABLE 106. GLOBAL COLLAGEN VASCULAR DISEASES MARKET SIZE, BY ONLINE PHARMACIES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 107. GLOBAL COLLAGEN VASCULAR DISEASES MARKET SIZE, BY ONLINE PHARMACIES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 108. GLOBAL COLLAGEN VASCULAR DISEASES MARKET SIZE, BY RETAIL PHARMACIES, BY REGION, 2018-2032 (USD MILLION)
TABLE 109. GLOBAL COLLAGEN VASCULAR DISEASES MARKET SIZE, BY RETAIL PHARMACIES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 110. GLOBAL COLLAGEN VASCULAR DISEASES MARKET SIZE, BY RETAIL PHARMACIES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 111. GLOBAL COLLAGEN VASCULAR DISEASES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 112. AMERICAS COLLAGEN VASCULAR DISEASES MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
TABLE 113. AMERICAS COLLAGEN VASCULAR DISEASES MARKET SIZE, BY DISEASE INDICATION, 2018-2032 (USD MILLION)
TABLE 114. AMERICAS COLLAGEN VASCULAR DISEASES MARKET SIZE, BY VASCULITIS, 2018-2032 (USD MILLION)
TABLE 115. AMERICAS COLLAGEN VASCULAR DISEASES MARKET SIZE, BY LARGE VESSEL VASCULITIS, 2018-2032 (USD MILLION)
TABLE 116. AMERICAS COLLAGEN VASCULAR DISEASES MARKET SIZE, BY MEDIUM VESSEL VASCULITIS, 2018-2032 (USD MILLION)
TABLE 117. AMERICAS COLLAGEN VASCULAR DISEASES MARKET SIZE, BY SMALL VESSEL VASCULITIS, 2018-2032 (USD MILLION)
TABLE 118. AMERICAS COLLAGEN VASCULAR DISEASES MARKET SIZE, BY THERAPY TYPE, 2018-2032 (USD MILLION)
TABLE 119. AMERICAS COLLAGEN VASCULAR DISEASES MARKET SIZE, BY BIOLOGICS, 2018-2032 (USD MILLION)
TABLE 120. AMERICAS COLLAGEN VASCULAR DISEASES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 121. AMERICAS COLLAGEN VASCULAR DISEASES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 122. AMERICAS COLLAGEN VASCULAR DISEASES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 123. NORTH AMERICA COLLAGEN VASCULAR DISEASES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 124. NORTH AMERICA COLLAGEN VASCULAR DISEASES MARKET SIZE, BY DISEASE INDICATION, 2018-2032 (USD MILLION)
TABLE 125. NORTH AMERICA COLLAGEN VASCULAR DISEASES MARKET SIZE, BY VASCULITIS, 2018-2032 (USD MILLION)
TABLE 126. NORTH AMERICA COLLAGEN VASCULAR DISEASES MARKET SIZE, BY LARGE VESSEL VASCULITIS, 2018-2032 (USD MILLION)
TABLE 127. NORTH AMERICA COLLAGEN VASCULAR DISEASES MARKET SIZE, BY MEDIUM VESSEL VASCULITIS, 2018-2032 (USD MILLION)
TABLE 128. NORTH AMERICA COLLAGEN VASCULAR DISEASES MARKET SIZE, BY SMALL VESSEL VASCULITIS, 2018-2032 (USD MILLION)
TABLE 129. NORTH AMERICA COLLAGEN VASCULAR DISEASES MARKET SIZE, BY THERAPY TYPE, 2018-2032 (USD MILLION)
TABLE 130. NORTH AMERICA COLLAGEN VASCULAR DISEASES MARKET SIZE, BY BIOLOGICS, 2018-2032 (USD MILLION)
TABLE 131. NORTH AMERICA COLLAGEN VASCULAR DISEASES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 132. NORTH AMERICA COLLAGEN VASCULAR DISEASES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 133. NORTH AMERICA COLLAGEN VASCULAR DISEASES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 134. LATIN AMERICA COLLAGEN VASCULAR DISEASES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 135. LATIN AMERICA COLLAGEN VASCULAR DISEASES MARKET SIZE, BY DISEASE INDICATION, 2018-2032 (USD MILLION)
TABLE 136. LATIN AMERICA COLLAGEN VASCULAR DISEASES MARKET SIZE, BY VASCULITIS, 2018-2032 (USD MILLION)
TABLE 137. LATIN AMERICA COLLAGEN VASCULAR DISEASES MARKET SIZE, BY LARGE VESSEL VASCULITIS, 2018-2032 (USD MILLION)
TABLE 138. LATIN AMERICA COLLAGEN VASCULAR DISEASES MARKET SIZE, BY MEDIUM VESSEL VASCULITIS, 2018-2032 (USD MILLION)
TABLE 139. LATIN AMERICA COLLAGEN VASCULAR DISEASES MARKET SIZE, BY SMALL VESSEL VASCULITIS, 2018-2032 (USD MILLION)
TABLE 140. LATIN AMERICA COLLAGEN VASCULAR DISEASES MARKET SIZE, BY THERAPY TYPE, 2018-2032 (USD MILLION)
TABLE 141. LATIN AMERICA COLLAGEN VASCULAR DISEASES MARKET SIZE, BY BIOLOGICS, 2018-2032 (USD MILLION)
TABLE 142. LATIN AMERICA COLLAGEN VASCULAR DISEASES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 143. LATIN AMERICA COLLAGEN VASCULAR DISEASES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 144. LATIN AMERICA COLLAGEN VASCULAR DISEASES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 145. EUROPE, MIDDLE EAST & AFRICA COLLAGEN VASCULAR DISEASES MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
TABLE 146. EUROPE, MIDDLE EAST & AFRICA COLLAGEN VASCULAR DISEASES MARKET SIZE, BY DISEASE INDICATION, 2018-2032 (USD MILLION)
TABLE 147. EUROPE, MIDDLE EAST & AFRICA COLLAGEN VASCULAR DISEASES MARKET SIZE, BY VASCULITIS, 2018-2032 (USD MILLION)
TABLE 148. EUROPE, MIDDLE EAST & AFRICA COLLAGEN VASCULAR DISEASES MARKET SIZE, BY LARGE VESSEL VASCULITIS, 2018-2032 (USD MILLION)
TABLE 149. EUROPE, MIDDLE EAST & AFRICA COLLAGEN VASCULAR DISEASES MARKET SIZE, BY MEDIUM VESSEL VASCULITIS, 2018-2032 (USD MILLION)
TABLE 150. EUROPE, MIDDLE EAST & AFRICA COLLAGEN VASCULAR DISEASES MARKET SIZE, BY SMALL VESSEL VASCULITIS, 2018-2032 (USD MILLION)
TABLE 151. EUROPE, MIDDLE EAST & AFRICA COLLAGEN VASCULAR DISEASES MARKET SIZE, BY THERAPY TYPE, 2018-2032 (USD MILLION)
TABLE 152. EUROPE, MIDDLE EAST & AFRICA COLLAGEN VASCULAR DISEASES MARKET SIZE, BY BIOLOGICS, 2018-2032 (USD MILLION)
TABLE 153. EUROPE, MIDDLE EAST & AFRICA COLLAGEN VASCULAR DISEASES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 154. EUROPE, MIDDLE EAST & AFRICA COLLAGEN VASCULAR DISEASES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 155. EUROPE, MIDDLE EAST & AFRICA COLLAGEN VASCULAR DISEASES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 156. EUROPE COLLAGEN VASCULAR DISEASES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 157. EUROPE COLLAGEN VASCULAR DISEASES MARKET SIZE, BY DISEASE INDICATION, 2018-2032 (USD MILLION)
TABLE 158. EUROPE COLLAGEN VASCULAR DISEASES MARKET SIZE, BY VASCULITIS, 2018-2032 (USD MILLION)
TABLE 159. EUROPE COLLAGEN VASCULAR DISEASES MARKET SIZE, BY LARGE VESSEL VASCULITIS, 2018-2032 (USD MILLION)
TABLE 160. EUROPE COLLAGEN VASCULAR DISEASES MARKET SIZE, BY MEDIUM VESSEL VASCULITIS, 2018-2032 (USD MILLION)
TABLE 161. EUROPE COLLAGEN VASCULAR DISEASES MARKET SIZE, BY SMALL VESSEL VASCULITIS, 2018-2032 (USD MILLION)
TABLE 162. EUROPE COLLAGEN VASCULAR DISEASES MARKET SIZE, BY THERAPY TYPE, 2018-2032 (USD MILLION)
TABLE 163. EUROPE COLLAGEN VASCULAR DISEASES MARKET SIZE, BY BIOLOGICS, 2018-2032 (USD MILLION)
TABLE 164. EUROPE COLLAGEN VASCULAR DISEASES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 165. EUROPE COLLAGEN VASCULAR DISEASES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 166. EUROPE COLLAGEN VASCULAR DISEASES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 167. MIDDLE EAST COLLAGEN VASCULAR DISEASES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 168. MIDDLE EAST COLLAGEN VASCULAR DISEASES MARKET SIZE, BY DISEASE INDICATION, 2018-2032 (USD MILLION)
TABLE 169. MIDDLE EAST COLLAGEN VASCULAR DISEASES MARKET SIZE, BY VASCULITIS, 2018-2032 (USD MILLION)
TABLE 170. MIDDLE EAST COLLAGEN VASCULAR DISEASES MARKET SIZE, BY LARGE VESSEL VASCULITIS, 2018-2032 (USD MILLION)
TABLE 171. MIDDLE EAST COLLAGEN VASCULAR DISEASES MARKET SIZE, BY MEDIUM VESSEL VASCULITIS, 2018-2032 (USD MILLION)
TABLE 172. MIDDLE EAST COLLAGEN VASCULAR DISEASES MARKET SIZE, BY SMALL VESSEL VASCULITIS, 2018-2032 (USD MILLION)
TABLE 173. MIDDLE EAST COLLAGEN VASCULAR DISEASES MARKET SIZE, BY THERAPY TYPE, 2018-2032 (USD MILLION)
TABLE 174. MIDDLE EAST COLLAGEN VASCULAR DISEASES MARKET SIZE, BY BIOLOGICS, 2018-2032 (USD MILLION)
TABLE 175. MIDDLE EAST COLLAGEN VASCULAR DISEASES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 176. MIDDLE EAST COLLAGEN VASCULAR DISEASES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 177. MIDDLE EAST COLLAGEN VASCULAR DISEASES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 178. AFRICA COLLAGEN VASCULAR DISEASES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 179. AFRICA COLLAGEN VASCULAR DISEASES MARKET SIZE, BY DISEASE INDICATION, 2018-2032 (USD MILLION)
TABLE 180. AFRICA COLLAGEN VASCULAR DISEASES MARKET SIZE, BY VASCULITIS, 2018-2032 (USD MILLION)
TABLE 181. AFRICA COLLAGEN VASCULAR DISEASES MARKET SIZE, BY LARGE VESSEL VASCULITIS, 2018-2032 (USD MILLION)
TABLE 182. AFRICA COLLAGEN VASCULAR DISEASES MARKET SIZE, BY MEDIUM VESSEL VASCULITIS, 2018-2032 (USD MILLION)
TABLE 183. AFRICA COLLAGEN VASCULAR DISEASES MARKET SIZE, BY SMALL VESSEL VASCULITIS, 2018-2032 (USD MILLION)
TABLE 184. AFRICA COLLAGEN VASCULAR DISEASES MARKET SIZE, BY THERAPY TYPE, 2018-2032 (USD MILLION)
TABLE 185. AFRICA COLLAGEN VASCULAR DISEASES MARKET SIZE, BY BIOLOGICS, 2018-2032 (USD MILLION)
TABLE 186. AFRICA COLLAGEN VASCULAR DISEASES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 187. AFRICA COLLAGEN VASCULAR DISEASES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 188. AFRICA COLLAGEN VASCULAR DISEASES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 189. ASIA-PACIFIC COLLAGEN VASCULAR DISEASES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 190. ASIA-PACIFIC COLLAGEN VASCULAR DISEASES MARKET SIZE, BY DISEASE INDICATION, 2018-2032 (USD MILLION)
TABLE 191. ASIA-PACIFIC COLLAGEN VASCULAR DISEASES MARKET SIZE, BY VASCULITIS, 2018-2032 (USD MILLION)
TABLE 192. ASIA-PACIFIC COLLAGEN VASCULAR DISEASES MARKET SIZE, BY LARGE VESSEL VASCULITIS, 2018-2032 (USD MILLION)
TABLE 193. ASIA-PACIFIC COLLAGEN VASCULAR DISEASES MARKET SIZE, BY MEDIUM VESSEL VASCULITIS, 2018-2032 (USD MILLION)
TABLE 194. ASIA-PACIFIC COLLAGEN VASCULAR DISEASES MARKET SIZE, BY SMALL VESSEL VASCULITIS, 2018-2032 (USD MILLION)
TABLE 195. ASIA-PACIFIC COLLAGEN VASCULAR DISEASES MARKET SIZE, BY THERAPY TYPE, 2018-2032 (USD MILLION)
TABLE 196. ASIA-PACIFIC COLLAGEN VASCULAR DISEASES MARKET SIZE, BY BIOLOGICS, 2018-2032 (USD MILLION)
TABLE 197. ASIA-PACIFIC COLLAGEN VASCULAR DISEASES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 198. ASIA-PACIFIC COLLAGEN VASCULAR DISEASES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 199. ASIA-PACIFIC COLLAGEN VASCULAR DISEASES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 200. GLOBAL COLLAGEN VASCULAR DISEASES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 201. ASEAN COLLAGEN VASCULAR DISEASES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 202. ASEAN COLLAGEN VASCULAR DISEASES MARKET SIZE, BY DISEASE INDICATION, 2018-2032 (USD MILLION)
TABLE 203. ASEAN COLLAGEN VASCULAR DISEASES MARKET SIZE, BY VASCULITIS, 2018-2032 (USD MILLION)
TABLE 204. ASEAN COLLAGEN VASCULAR DISEASES MARKET SIZE, BY LARGE VESSEL VASCULITIS, 2018-2032 (USD MILLION)
TABLE 205. ASEAN COLLAGEN VASCULAR DISEASES MARKET SIZE, BY MEDIUM VESSEL VASCULITIS, 2018-2032 (USD MILLION)
TABLE 206. ASEAN COLLAGEN VASCULAR DISEASES MARKET SIZE, BY SMALL VESSEL VASCULITIS, 2018-2032 (USD MILLION)
TABLE 207. ASEAN COLLAGEN VASCULAR DISEASES MARKET SIZE, BY THERAPY TYPE, 2018-2032 (USD MILLION)
TABLE 208. ASEAN COLLAGEN VASCULAR DISEASES MARKET SIZE, BY BIOLOGICS, 2018-2032 (USD MILLION)
TABLE 209. ASEAN COLLAGEN VASCULAR DISEASES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 210. ASEAN COLLAGEN VASCULAR DISEASES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 211. ASEAN COLLAGEN VASCULAR DISEASES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 212. GCC COLLAGEN VASCULAR DISEASES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 213. GCC COLLAGEN VASCULAR DISEASES MARKET SIZE, BY DISEASE INDICATION, 2018-2032 (USD MILLION)
TABLE 214. GCC COLLAGEN VASCULAR DISEASES MARKET SIZE, BY VASCULITIS, 2018-2032 (USD MILLION)
TABLE 215. GCC COLLAGEN VASCULAR DISEASES MARKET SIZE, BY LARGE VESSEL VASCULITIS, 2018-2032 (USD MILLION)
TABLE 216. GCC COLLAGEN VASCULAR DISEASES MARKET SIZE, BY MEDIUM VESSEL VASCULITIS, 2018-2032 (USD MILLION)
TABLE 217. GCC COLLAGEN VASCULAR DISEASES MARKET SIZE, BY SMALL VESSEL VASCULITIS, 2018-2032 (USD MILLION)
TABLE 218. GCC COLLAGEN VASCULAR DISEASES MARKET SIZE, BY THERAPY TYPE, 2018-2032 (USD MILLION)
TABLE 219. GCC COLLAGEN VASCULAR DISEASES MARKET SIZE, BY BIOLOGICS, 2018-2032 (USD MILLION)
TABLE 220. GCC COLLAGEN VASCULAR DISEASES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 221. GCC COLLAGEN VASCULAR DISEASES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 222. GCC COLLAGEN VASCULAR DISEASES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 223. EUROPEAN UNION COLLAGEN VASCULAR DISEASES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 224. EUROPEAN UNION COLLAGEN VASCULAR DISEASES MARKET SIZE, BY DISEASE INDICATION, 2018-2032 (USD MILLION)
TABLE 225. EUROPEAN UNION COLLAGEN VASCULAR DISEASES MARKET SIZE, BY VASCULITIS, 2018-2032 (USD MILLION)
TABLE 226. EUROPEAN UNION COLLAGEN VASCULAR DISEASES MARKET SIZE, BY LARGE VESSEL VASCULITIS, 2018-2032 (USD MILLION)
TABLE 227. EUROPEAN UNION COLLAGEN VASCULAR DISEASES MARKET SIZE, BY MEDIUM VESSEL VASCULITIS, 2018-2032 (USD MILLION)
TABLE 228. EUROPEAN UNION COLLAGEN VASCULAR DISEASES MARKET SIZE, BY SMALL VESSEL VASCULITIS, 2018-2032 (USD MILLION)
TABLE 229. EUROPEAN UNION COLLAGEN VASCULAR DISEASES MARKET SIZE, BY THERAPY TYPE, 2018-2032 (USD MILLION)
TABLE 230. EUROPEAN UNION COLLAGEN VASCULAR DISEASES MARKET SIZE, BY BIOLOGICS, 2018-2032 (USD MILLION)
TABLE 231. EUROPEAN UNION COLLAGEN VASCULAR DISEASES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 232. EUROPEAN UNION COLLAGEN VASCULAR DISEASES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 233. EUROPEAN UNION COLLAGEN VASCULAR DISEASES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 234. BRICS COLLAGEN VASCULAR DISEASES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 235. BRICS COLLAGEN VASCULAR DISEASES MARKET SIZE, BY DISEASE INDICATION, 2018-2032 (USD MILLION)
TABLE 236. BRICS COLLAGEN VASCULAR DISEASES MARKET SIZE, BY VASCULITIS, 2018-2032 (USD MILLION)
TABLE 237. BRICS COLLAGEN VASCULAR DISEASES MARKET SIZE, BY LARGE VESSEL VASCULITIS, 2018-2032 (USD MILLION)
TABLE 238. BRICS COLLAGEN VASCULAR DISEASES MARKET SIZE, BY MEDIUM VESSEL VASCULITIS, 2018-2032 (USD MILLION)
TABLE 239. BRICS COLLAGEN VASCULAR DISEASES MARKET SIZE, BY SMALL VESSEL VASCULITIS, 2018-2032 (USD MILLION)
TABLE 240. BRICS COLLAGEN VASCULAR DISEASES MARKET SIZE, BY THERAPY TYPE, 2018-2032 (USD MILLION)
TABLE 241. BRICS COLLAGEN VASCULAR DISEASES MARKET SIZE, BY BIOLOGICS, 2018-2032 (USD MILLION)
TABLE 242. BRICS COLLAGEN VASCULAR DISEASES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 243. BRICS COLLAGEN VASCULAR DISEASES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 244. BRICS COLLAGEN VASCULAR DISEASES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 245. G7 COLLAGEN VASCULAR DISEASES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 246. G7 COLLAGEN VASCULAR DISEASES MARKET SIZE, BY DISEASE INDICATION, 2018-2032 (USD MILLION)
TABLE 247. G7 COLLAGEN VASCULAR DISEASES MARKET SIZE, BY VASCULITIS, 2018-2032 (USD MILLION)
TABLE 248. G7 COLLAGEN VASCULAR DISEASES MARKET SIZE, BY LARGE VESSEL VASCULITIS, 2018-2032 (USD MILLION)
TABLE 249. G7 COLLAGEN VASCULAR DISEASES MARKET SIZE, BY MEDIUM VESSEL VASCULITIS, 2018-2032 (USD MILLION)
TABLE 250. G7 COLLAGEN VASCULAR DISEASES MARKET SIZE, BY SMALL VESSEL VASCULITIS, 2018-2032 (USD MILLION)
TABLE 251. G7 COLLAGEN VASCULAR DISEASES MARKET SIZE, BY THERAPY TYPE, 2018-2032 (USD MILLION)
TABLE 252. G7 COLLAGEN VASCULAR DISEASES MARKET SIZE, BY BIOLOGICS, 2018-2032 (USD MILLION)
TABLE 253. G7 COLLAGEN VASCULAR DISEASES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 254. G7 COLLAGEN VASCULAR DISEASES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 255. G7 COLLAGEN VASCULAR DISEASES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 256. NATO COLLAGEN VASCULAR DISEASES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 257. NATO COLLAGEN VASCULAR DISEASES MARKET SIZE, BY DISEASE INDICATION, 2018-2032 (USD MILLION)
TABLE 258. NATO COLLAGEN VASCULAR DISEASES MARKET SIZE, BY VASCULITIS, 2018-2032 (USD MILLION)
TABLE 259. NATO COLLAGEN VASCULAR DISEASES MARKET SIZE, BY LARGE VESSEL VASCULITIS, 2018-2032 (USD MILLION)
TABLE 260. NATO COLLAGEN VASCULAR DISEASES MARKET SIZE, BY MEDIUM VESSEL VASCULITIS, 2018-2032 (USD MILLION)
TABLE 261. NATO COLLAGEN VASCULAR DISEASES MARKET SIZE, BY SMALL VESSEL VASCULITIS, 2018-2032 (USD MILLION)
TABLE 262. NATO COLLAGEN VASCULAR DISEASES MARKET SIZE, BY THERAPY TYPE, 2018-2032 (USD MILLION)
TABLE 263. NATO COLLAGEN VASCULAR DISEASES MARKET SIZE, BY BIOLOGICS, 2018-2032 (USD MILLION)
TABLE 264. NATO COLLAGEN VASCULAR DISEASES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 265. NATO COLLAGEN VASCULAR DISEASES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 266. NATO COLLAGEN VASCULAR DISEASES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 267. GLOBAL COLLAGEN VASCULAR DISEASES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 268. UNITED STATES COLLAGEN VASCULAR DISEASES MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 269. UNITED STATES COLLAGEN VASCULAR DISEASES MARKET SIZE, BY DISEASE INDICATION, 2018-2032 (USD MILLION)
TABLE 270. UNITED STATES COLLAGEN VASCULAR DISEASES MARKET SIZE, BY VASCULITIS, 2018-2032 (USD MILLION)
TABLE 271. UNITED STATES COLLAGEN VASCULAR DISEASES MARKET SIZE, BY LARGE VESSEL VASCULITIS, 2018-2032 (USD MILLION)
TABLE 272. UNITED STATES COLLAGEN VASCULAR DISEASES MARKET SIZE, BY MEDIUM VESSEL VASCULITIS, 2018-2032 (USD MILLION)
TABLE 273. UNITED STATES COLLAGEN VASCULAR DISEASES MARKET SIZE, BY SMALL VESSEL VASCULITIS, 2018-2032 (USD MILLION)
TABLE 274. UNITED STATES COLLAGEN VASCULAR DISEASES MARKET SIZE, BY THERAPY TYPE, 2018-2032 (USD MILLION)
TABLE 275. UNITED STATES COLLAGEN VASCULAR DISEASES MARKET SIZE, BY BIOLOGICS, 2018-2032 (USD MILLION)
TABLE 276. UNITED STATES COLLAGEN VASCULAR DISEASES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 277. UNITED STATES COLLAGEN VASCULAR DISEASES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 278. UNITED STATES COLLAGEN VASCULAR DISEASES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 279. CHINA COLLAGEN VASCULAR DISEASES MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 280. CHINA COLLAGEN VASCULAR DISEASES MARKET SIZE, BY DISEASE INDICATION, 2018-2032 (USD MILLION)
TABLE 281. CHINA COLLAGEN VASCULAR DISEASES MARKET SIZE, BY VASCULITIS, 2018-2032 (USD MILLION)
TABLE 282. CHINA COLLAGEN VASCULAR DISEASES MARKET SIZE, BY LARGE VESSEL VASCULITIS, 2018-2032 (USD MILLION)
TABLE 283. CHINA COLLAGEN VASCULAR DISEASES MARKET SIZE, BY MEDIUM VESSEL VASCULITIS, 2018-2032 (USD MILLION)
TABLE 284. CHINA COLLAGEN VASCULAR DISEASES MARKET SIZE, BY SMALL VESSEL VASCULITIS, 2018-2032 (USD MILLION)
TABLE 285. CHINA COLLAGEN VASCULAR DISEASES MARKET SIZE, BY THERAPY TYPE, 2018-2032 (USD MILLION)
TABLE 286. CHINA COLLAGEN VASCULAR DISEASES MARKET SIZE, BY BIOLOGICS, 2018-2032 (USD MILLION)
TABLE 287. CHINA COLLAGEN VASCULAR DISEASES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 288. CHINA COLLAGEN VASCULAR DISEASES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 289. CHINA COLLAGEN VASCULAR DISEASES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)

Companies Mentioned

The key companies profiled in this Collagen Vascular Diseases market report include:
  • Abbott Laboratories
  • AbbVie Inc.
  • Apollo Health and Lifestyle Limited
  • Augurex Life Sciences Corporation
  • Bayer AG
  • Beckman Coulter, Inc.
  • Bio-Rad Laboratories Inc.
  • Boehringer Ingelheim International GmbH
  • Bristol-Myers Squibb
  • Bristol-Myers Squibb Company
  • Eli Lilly and Company
  • Exagen Inc.
  • F. Hoffmann-La Roche Ltd
  • Getinge AB
  • Gilead Sciences, Inc.
  • GlaxoSmithKline plc
  • Illumina, Inc.
  • Johnson & Johnson
  • Laboratory Corporation of America Holdings
  • LeMaitre Vascular, Inc.
  • Merck KGaA
  • Novartis AG
  • PerkinElmer, Inc.
  • Pfizer Inc,
  • QIAGEN GmbH
  • Roche Holding AG
  • Sanofi S.A.
  • Siemens AG
  • Thermo Fisher Scientific, Inc.
  • UCB S.A.

Table Information

Report AttributeDetails
No. of Pages191
PublishedJanuary 2026
Forecast Period2026 - 2032
Estimated Market Value ( USD ) in 2026 $ 38.21 Billion
Forecasted Market Value ( USD ) by 2032 $ 64.51 Billion
Compound Annual Growth Rate9.0%
Regions CoveredGlobal
No. of Companies Mentioned31

Related Topics

Related Reports

Ehlers-Danlos Syndrome - Market Insight, Epidemiology, and Market Forecast - 2034 - Product Image

Ehlers-Danlos Syndrome - Market Insight, Epidemiology, and Market Forecast - 2034

  • Report
  • 200 Pages
  • Global
From
Scleroderma - Pipeline Insight, 2025 - Product Image

Scleroderma - Pipeline Insight, 2025

  • Clinical Trials
  • 180 Pages
  • Global
From
Biosimilar Monoclonal Antibodies Market - Global Forecast 2026-2032 - Product Image

Biosimilar Monoclonal Antibodies Market - Global Forecast 2026-2032

  • Report
  • 184 Pages
  • Global
From
Systemic Scleroderma Drug Pipeline Analysis Report 2025 - Product Image

Systemic Scleroderma Drug Pipeline Analysis Report 2025

  • Drug Pipelines
  • 200 Pages
  • Global
From
Kallikrein Inhibitors Market - Global Forecast 2026-2032 - Product Image

Kallikrein Inhibitors Market - Global Forecast 2026-2032

  • Report
  • 180 Pages
  • Global
From

About the Collagen Vascular Disease Drug Market

Collagen Vascular Disease (CVD) Drug is a type of drug used to treat immune disorders. These drugs are used to reduce inflammation and suppress the immune system, which can help reduce the symptoms of CVD. They can also help to reduce the risk of complications from CVD, such as organ damage. CVD drugs are typically prescribed by a doctor and can be taken orally or intravenously. Common CVD drugs include corticosteroids, immunosuppressants, and biologics. Corticosteroids are used to reduce inflammation and suppress the immune system, while immunosuppressants are used to reduce the activity of the immune system. Biologics are used to target specific parts of the immune system and can be used to treat specific conditions. The CVD Drug market is a growing market, with many companies offering a variety of drugs to treat CVD. Some of the major companies in the market include AbbVie, Amgen, AstraZeneca, Bristol-Myers Squibb, Eli Lilly, GlaxoSmithKline, Merck, Novartis, Pfizer, and Sanofi. Show Less Read more

Copyright © 2002-2026 Research and Markets. All Rights Reserved.